Adicet Bio ACET
$ 0.97
0.0%
Quarterly report 2024-Q3
added 11-06-2024
Adicet Bio Financial Ratios 2011-2024 | ACET
Annual Financial Ratios Adicet Bio
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -4.5 | -8.7 | -1.7 | -10.3 | 298.2 | 12.7 | 21.1 | 21.3 | 19.7 | - | - | - |
P/S |
- | - | 55.6 | 3.6 | 290.7 | 5.3 | 0.8 | 1.3 | 1.2 | 0.9 | - | - | - |
EPS |
-3.3 | -1.7 | -2 | -5.0 | -13.2 | -4.8 | -8.4 | - | - | - | - | - | - |
EV (Enterprise Value) |
-35.2 M | 97.8 M | 300 M | 23.7 M | 397 M | 665 M | 580 M | 236 M | 236 M | 234 M | 129 M | 131 M | 151 M |
EBITDA per Share |
-3.39 | -1.7 | -1.94 | -7.29 | -0.934 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-4.7 | 0.3 | -9.2 | 55.3 | 9.9 | 11.1 | 13.3 | 12.2 | - | - | - | ||
PEG |
- | 0.06 | 0.05 | -1.64 | -13.1 | -21.59 | -21.24 | -18.95 | - | - | - | ||
P/B |
0.5 | 1.1 | 1.8 | 0.6 | -4.8 | 35.6 | 1.1 | 2.3 | 2.4 | 1.9 | - | - | - |
P/CF |
-0.9 | -7.1 | -10.6 | -1.5 | -10.0 | 86.3 | 22.6 | 114.9 | 26.7 | 19.2 | - | - | - |
ROE % |
-83.83 | -23.87 | -20.45 | -33.40 | 46.61 | 11.94 | 8.58 | 11.00 | 11.41 | 9.56 | - | - | - |
ROA % |
-68.82 | -21.10 | -18.29 | -23.84 | -34.49 | 1.48 | 3.35 | 6.19 | 5.92 | 4.77 | - | - | - |
ROCE % |
-89.34 | -24.82 | -20.27 | -29.84 | -47.04 | 6.58 | 6.60 | 12.19 | 12.25 | 9.89 | - | - | - |
Current Ratio |
5.6 | 8.6 | 9.5 | 4.5 | 4.3 | 1.7 | 2.1 | 3.6 | 2.5 | 2.3 | - | - | - |
DSO |
- | - | - | 55.7 | 343.0 | 141.4 | 170.5 | 111.9 | 115.6 | 89.6 | - | - | - |
DIO |
- | - | - | - | - | 100.6 | 119.7 | 87.0 | 88.2 | 91.5 | - | - | - |
DPO |
- | - | - | - | - | 78.3 | 79.0 | 40.8 | 50.7 | 44.3 | - | - | - |
Operating Cycle |
- | - | - | - | - | 241.9 | 290.2 | 198.9 | 203.8 | 181.2 | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | 163.6 | 211.2 | 158.0 | 153.1 | 136.9 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Adicet Bio
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.34 | -0.33 | -0.35 | - | -1.16 | -0.75 | -0.72 | - | -0.53 | -0.56 | 0.12 | - | -0.44 | -0.34 | -0.82 | - | -2.84 | -3.88 | -2.07 | -0.79 | -6.87 | -0.51 | -0.38 | -0.21 | -0.3 | -0.48 | -0.46 | -5.11 | -0.75 | -0.94 | -1.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.37 | - | -1.18 | -0.78 | -0.75 | - | -0.53 | -0.56 | 0.13 | - | -0.42 | -0.32 | -0.81 | - | -2.56 | -3.83 | -3.35 | -13.7 | -6.94 | -0.54 | -0.4 | -0.23 | -0.32 | -0.5 | -0.47 | -1.33 | -0.89 | -0.94 | -1.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-63.58 | -74.79 | -75.63 | -50.78 | -57.70 | -39.00 | -33.13 | -13.13 | -19.58 | -19.10 | -16.17 | -20.23 | -33.68 | -40.69 | -43.64 | -25.24 | 22.62 | 60.56 | 65.01 | 64.04 | 33.36 | 0.81 | -8.99 | -13.39 | 54.98 | 73.41 | 99.16 | 119.14 | 33.59 | 23.22 | 10.51 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-54.46 | -63.45 | -64.00 | -43.18 | -49.39 | -34.21 | -29.37 | -11.68 | -17.13 | -16.37 | -13.58 | -17.04 | -26.65 | -30.81 | -32.27 | -18.02 | -53.43 | -61.94 | -59.26 | -60.74 | -30.57 | -20.11 | -29.64 | -34.21 | -70.75 | -69.10 | -64.09 | -61.20 | -19.43 | -13.43 | -6.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-68.42 | -79.59 | -80.21 | -53.96 | -61.19 | -41.58 | -34.73 | -13.47 | -19.78 | -18.85 | -15.85 | -20.09 | -32.52 | -38.65 | -41.76 | -27.17 | 21.59 | 59.25 | 43.64 | 36.21 | 6.42 | -27.46 | -17.55 | -13.02 | -4.08 | 16.94 | 43.19 | 63.49 | 35.58 | 23.22 | 10.51 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.1 | 8.0 | 8.6 | 5.6 | 6.0 | 7.2 | 7.9 | 8.6 | 9.7 | 9.0 | 11.6 | 9.5 | 6.4 | 6.7 | 6.2 | 3.5 | 3.5 | 3.5 | 3.5 | 2.9 | 2.9 | 7.7 | 7.7 | 19.2 | 19.2 | 19.2 | 19.2 | 10.0 | 10.0 | 10.0 | 10.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency